CAROL VOS: Open Payments
NPI 1902868896 · TEMPLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$378 in 20 payments from 10 companies in 2025. Trend: 2023 $365 · 2024 $364 · 2025 $378
Food & beverage: $378
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $153 |
| Astellas Pharma US Inc | 3 | $54 |
| Exact Sciences Corporation | 2 | $40 |
| ABBVIE INC. | 1 | $28 |
| Abbott Laboratories | 1 | $21 |
| SANOFI PASTEUR INC. | 1 | $19 |
| Lilly USA, LLC | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Dexcom, Inc. | 1 | $14 |
Products named: Wegovy, Veozah, Ozempic, Cologuard Collection Kit, LINZESS, FREESTYLE LIBRE 3, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, MOUNJARO.
Industry payments across TX — which companies pay providers there.
